Back to search

Article

OpenSAFELY: Do adults prescribed non-steroidal anti-inflammatory drugs have an increased risk of death from COVID-19?

2020-08-14

Abstract excerpt

<h4>Importance</h4> There has been speculation that non-steroidal anti-inflammatory drugs (NSAIDs) may negatively affect coronavirus disease 2019 (COVID-19) outcomes, yet clinical evidence is limited. <h4>Objective</h4> To assess the association between NSAID use and deaths from COVID-19 using OpenSAFELY, a secure analytical platform. <h4>Design</h4> Two cohort studies (1 st March-14 th June 2020). <h4>Setting</h4...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
050b711e-a3f3-52eb-aa01-ab81a5895e7e
DOI
10.1101/2020.08.12.20171405
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
OpenSAFELY: Do adults prescribed non-steroidal anti-inflammatory drugs have an increased risk of death from COVID-19?DOI 10.1101/2020.08.12.20171405
Prevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysisSemantic proximity
Prevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysisSemantic proximity
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platformSemantic proximity
Currently prescribed drugs in the UK that could up or downregulate ACE2 in COVID-19 disease: A systematic reviewSemantic proximity
Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELYSemantic proximity
Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replicationSemantic proximity
NSAIDs/Nitazoxanide/Azithromycin Repurposed for COVID-19: Potential Mitigation of the Cytokine Storm Interleukin-6 Amplifier via Immunomodulatory EffectsSemantic proximity
Changes in opioid prescribing during the COVID-19 pandemic in England: cohort study of 20 million patients in OpenSAFELY-TPPSemantic proximity
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide, and methotrexate monitoring, and factors associated with change in monitoring rateSemantic proximity
Use of over-the-counter-like drugs among adults with indicated chronic diseases: A nationwide descriptive study in JapanSemantic proximity
Generation of Risk Score for Serious Non-Steroidal Anti-Inflammatory Drug (NSAID) Induced Cardiovascular Events (NAÏVE) among Active-Duty Service Members and VeteransSemantic proximity
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in ScotlandSemantic proximity
Select a neighboring publication to make it the new centre.